Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Plastic and Reconstructive Surgery
|
October 7, 2015
Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Upper Face (Glabella, Forehead, and Crow's Feet)
Gary Monheit
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
November 26, 2019
Mohs Surgery for Periocular Tumors
Gary Monheit, Katherine Hrynewycz
Journal of Drugs in Dermatology : JDD
|
August 4, 2012
Hyaluronic acid fillers on the horizon: roundtable discussion
Gary Monheit, Philippe Kestemont, Hema Sundaram
Expert Review of Clinical Pharmacology
|
July 27, 2016
ATX-101 (deoxycholic acid injection) for reduction of submental fat
Benjamin Ascher, Jere Fellmann, Gary Monheit
Aesthetic Surgery Journal
|
April 8, 2017
The Practical Use of AbobotulinumtoxinA in Aesthetics
Michael A C Kane, Gary Monheit
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 24, 2007
A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose
Gary Monheit, Alastair Carruthers, Fredric Brandt, et al.
Journal of Drugs in Dermatology : JDD
|
November 9, 2012
Consideration of muscle mass in glabellar line treatment with botulinum toxin type A
Gary Monheit, Xiaoming Lin, Diane Nelson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 11, 2017
Botulinum Toxin in Aesthetic Medicine: Myths and Realities
Jeffrey S Dover, Gary Monheit, Mark Greener, et al.
Archives of Facial Plastic Surgery
|
March 18, 2009
Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines
Ronald Moy, Corey Maas, Gary Monheit, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 13, 2011
Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A
Joel Schlessinger, Gary Monheit, Michael A C Kane, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Plastic and Reconstructive Surgery
|
October 7, 2015
Neurotoxins: Current Concepts in Cosmetic Use on the Face and Neck--Upper Face (Glabella, Forehead, and Crow's Feet)
Gary Monheit
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
November 26, 2019
Mohs Surgery for Periocular Tumors
Gary Monheit, Katherine Hrynewycz
Journal of Drugs in Dermatology : JDD
|
August 4, 2012
Hyaluronic acid fillers on the horizon: roundtable discussion
Gary Monheit, Philippe Kestemont, Hema Sundaram
Expert Review of Clinical Pharmacology
|
July 27, 2016
ATX-101 (deoxycholic acid injection) for reduction of submental fat
Benjamin Ascher, Jere Fellmann, Gary Monheit
Aesthetic Surgery Journal
|
April 8, 2017
The Practical Use of AbobotulinumtoxinA in Aesthetics
Michael A C Kane, Gary Monheit
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 24, 2007
A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose
Gary Monheit, Alastair Carruthers, Fredric Brandt, et al.
Journal of Drugs in Dermatology : JDD
|
November 9, 2012
Consideration of muscle mass in glabellar line treatment with botulinum toxin type A
Gary Monheit, Xiaoming Lin, Diane Nelson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 11, 2017
Botulinum Toxin in Aesthetic Medicine: Myths and Realities
Jeffrey S Dover, Gary Monheit, Mark Greener, et al.
Archives of Facial Plastic Surgery
|
March 18, 2009
Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines
Ronald Moy, Corey Maas, Gary Monheit, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
July 13, 2011
Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A
Joel Schlessinger, Gary Monheit, Michael A C Kane, et al.
Page
of 3